Who Paid My Doc
Ph2b_chronic urticaria
Research payments
$1,460,275
Through program year 2024, $1,460,275 in research payments was reported against Ph2b_chronic urticaria, across 112 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $7,003 | 4 |
| 2023 | Research | $43,330 | 9 |
| 2022 | Research | $593,795 | 48 |
| 2021 | Research | $816,148 | 51 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Weily Soong Birmingham, AL Named on 6 payments
- Jonathan Bernstein Cincinnati, OH Named on 5 payments
- Sarbjit Saini Baltimore, MD Named on 4 payments
- Sridhar Guduri Dublin, OH Named on 4 payments
- Vivian Laquer Irvine, CA Named on 4 payments
- Howard Sofen Los Angeles, CA Named on 4 payments
- Ellen Frankel Cranston, RI Named on 3 payments
- Jonathan Corren Los Angeles, CA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.